Skip to content
★ Sign in to follow
PA

Peggy A. Farley

CFO
U.S. Stem Cell, Inc.
Total declarations
7
Company
1
▲ Purchases (4 ops.)
€262k
▼ Sales (0 ops.)
—

Latest filing published 30 Apr 2010 for U.S. Stem Cell, Inc., €224k.

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
4
Positive at T+90
0%
Median T+90
-78.8%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 30 Apr 2010 · 6037 days ago · €224k
    -81.3%
    Entry US$800.00 · Close at T+365 US$150.00
  • Filed 04 Mar 2010 · 6094 days ago · €3,404
    -66.7%
    Entry US$600.00 · Close at T+365 US$200.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Peggy A. Farley: trading record in brief

Peggy A. Farley discloses dealings in U.S. Stem Cell, Inc. to SEC (Form 4). The record holds 7 filings, for trades running from 2 March 2009 to 20 April 2010.

Purchases make up the whole of the open-market record (4 purchases, €262k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants and 1 option exercise. 2010 to date brings 4 purchases and no sales.

The median purchase comes to €17k. Ninety days after publication, 3 purchases show a median change of -78.8%, with the price up in 0% of them. Past outcomes like these are no guarantee of what comes next.

The newest entry dates from 30 April 2010: an open-market purchase of €224k, in U.S. Stem Cell, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 10 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Peggy A. Farley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total

6 of 6 declarations